| Latest worldwide news
| Sarah Miller, Eric Gershon | | | The bride is a fellow at the National Science Foundation; the groom is a science writer in the Yale Office of Public Affairs and Communications. |
| Tired of revolving door parliaments, Kuwaitis vote, again | | | KUWAIT (Reuters) - A boycott by some opposition Islamists may help liberals and independents in Kuwait's election on Saturday, but there are signs that voters are flagging as they go to the polls for the sixth time in seven years. |
| U.S. chief executives can't break cost-cutting habit | | | (Reuters) - A disconcerting trend lurks beneath the recent round of solid profit forecasts announced by companies ranging from United Technologies Corp to Wendy's Co More than three years into the recovery, CEOs are still relying on cost cuts to prop up earnings. |
| TS Dorian weakens while moving rapidly westward NHC | | | Tropical storm Dorian, the fourth named storm of the Atlantic hurricane season, has become disorganized and is likely to weaken further over the next 48 hours, the U.S. National Hurricane Center said in its latest advisory. |
| 2 Editors Promoted at New York Times | | | Matt Purdy, the investigations editor, was named an assistant managing editor, and Marc Lacey, a deputy foreign editor, became an associate managing editor. |
| Police catch 'haiku' killer suspect | | | A 63-year-old man wanted in connection with the murder of five people in a remote Japanese hamlet has been captured after a manhunt involving more than 400 police. |
| Typhoon Soulik hits mainland China | | | Hundreds of thousands of people were evacuated Saturday along China's southeastern coast as Typhoon Soulik struck, where the storm was expected to bring strong winds and heavy rain. |
| Essay Flight Logs | | | Writing (and rewriting) his life story, Charles Lindbergh proved himself a skilled memoirist. |
| Boeing reshuffles 787 chief engineer, other commercial jobs | | | WASHINGTON, July 26 (Reuters) - Boeing Co said on Friday it had announced internally that it was rotating five executives in its commercial airplanes division, including Mike Sinnett, the chief engineer on the company's 787 Dreamliner, which has been hit by a series of technical challenges. |
| Ronaldinhos Last Hurrah? | | | Ronaldinho and Atletico Mineiro visit Olimpio of Paraguay on Wednesday night in the first leg of the finals in the Copa Libertadores. |
| The new age of the airship? | | | Once upon a time, the airship was hailed as the future of flight as glamorous, luxurious and fashionable as the Art Deco era which marked its heyday. |
| Football Mineiro lift Libertadores | | | Ronaldinho rounded on critics who said he was finished after he helped lead Brazilian side Atletico Mineiro to the Copa Libertadores title after a penalty shootout victory over Olimpia. |
| App Puts the Bible in 100 Million Palms | | | With more than 100 million downloads, YouVersion, a free app that offers over 600 Bible translations, has found itself in the company of successful start-ups like Instagram and Dropbox. |
| A boost for drained mobile devices - NY gets public solar charging stations | | | July 22 - New Yorkers in need of a charge can now head to public spaces, where solar powered charging stations offer a free boost to mobile devices. Apart from providing everyday convenience, the stations could be crucial during devastating power outages like those caused by Hurricane Sandy last year. Sharon Reich has more. |
| The Sweet Spot Why Netflix Matters | | | In this week's episode, A. O. Scott and David Carr talk about Netflix's amazing evolution, and how people are watching its critically acclaimed shows. |
| Mind doctor on McIlroy woe | | | When golfers admit to feeling "brain dead" and "unconscious" -- as Rory McIlroy did at Muirfield on Thursday -- perhaps it's time to book an appointment with the doctor. |
| UPDATE 1-US court permits generic version of Teva MS drug a year sooner | | | WASHINGTON/NEW YORK, July 26 (Reuters) - Teva Pharmaceutical Industries' $4 billion-a-year multiple sclerosis drug Copaxone will lose its patent protection in 2014 rather than 2015 because of a ruling from a U.S. appeals court on Friday, making it potentially prey to cheaper generics next May. |
| |
Комментариев нет:
Отправить комментарий